More information from http://www.researchandmarkets.com/reports/452447/
Executing Change in the Pharma Industry - Prescription for Pfizer
Description: Pharmaceutical history is littered with the abandoned husks of great ideas, many costing a king’s
ransom and never able to live up to their promise. Indeed, there is little doubt that in recent years
pharmaceutical companies have been getting their execution wrong. The key to future survival and
success is a company’s willingness to embrace change and adopt new approaches to execution.
Pfizer’s recent implosion speaks to the heart of the challenges facing the pharmaceutical industry
Dynamic changes are under way in this industry, and downsizing alone is unlikely to be enough to
save many companies. This report suggests several changes to both strategy and execution that
will help companies be viable in tomorrow’s marketplace. While there are both challenges to
overcome and pitfalls to avoid along the way, getting execution right now matters more than ever.
Get the Answers You Need to Shape Your Strategy
There is little doubt that in recent years, pharmaceutical companies have been getting their
execution wrong. What mistakes have been made and how can companies correct their execution
of strategic goals?
The cost structure of today’s pharmaceutical industry has changed. What procedures will improve
effectiveness in this new business environment?
A number of valuable opportunities for change exist for pharmaceutical management. What are
they, and how will they affect the success of the industry?
There are major impediments to change in the pharmaceutical industry. What are they, and how
can they be overcome?
-Basic concepts affecting and impeding company change: corporate culture, strategy versus
execution, behavior versus attitude, efficiency versus effectiveness.
-Pfizer: victim of its own success and prescription for change.
-Prescriptive plans for Pharma: simple strategies to improve execution of strategic goals.
-Cost-cutting: a vicious cycle of long-term, negative effects from short-term solutions.
-Marketing & selling: optimizing direct-to-consumer advertising and sales force size.
-Lipitor: useful as a litmus test for the impact of promotion on sales in the current market.
-Outsourcing and off shoring: cost-efficiencies that create tomorrow’s competition.
Contents: Executive Summary
Companies Have Been Getting Execution Wrong
Strategy and Execution
A Vicious Cycle Arises from Shedding Employees to Cut Costs
Knowledge/Organizational Size Disconnect
Marketing & Selling
Efficiency and Effectiveness in Pharmaceutical R&D
Wars of Attrition over Sales forces
Getting Execution Right Now Matters More Than Ever
Prescription for Pfizer
Pfizer in a Nutshell
Falling on Your Sword
Victim of Its Own Success
Look Beyond Simplistic Downsizing
Pfizer’s Current Predicament
Lipitor as a Litmus Test for the Impact of Promotion on Sales
Pfizer’s Pipeline Progress
Pressure to Find Sufficient New Products
Corporate Size Limits Available Targets for Development
Increased Product Opportunities for Smaller Companies
What Pharmaceutical Companies Can Learn from Pfizer’s Current Predicament
Five Quick Wins for Pharma
Downsizing the Sales force
Changing the Focus of DTC Promotion
The Bottom Line
The Curse of the Margin
The False Prophets of Outsourcing and Offshoring
Ordering: Order Online - http://www.researchandmarkets.com/reports/452447/
Order by Fax - using the form below
Order by Post - print the order form below and sent to
Research and Markets,
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
Please verify that the product information is correct.
Product Name: Executing Change in the Pharma Industry - Prescription for Pfizer
Web Address: http://www.researchandmarkets.com/reports/452447/
Office Code: OC8HPMLNONQQS
Please select the product format and quantity you require:
Electronic: EURO €765.00
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: Last Name:
Email Address: *
Postal / Zip Code:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Page 2 of 2
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card: American Express
(for Diners Club only)
Pay by check: Please post the check, accompanied by this form, to:
Research and Markets,
Please transfer funds to:
Pay by wire transfer:
Account number 833 130 83
Sort code 98-53-30
Swift code ULSBIE2D
IBAN number IE78ULSB98533083313083
Bank Address Ulster Bank,
27-35 Main Street,
If you have a Marketing Code please enter it below:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World